8 completed, 7 terminated. 7 Phase 3, 6 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Terminated 4, Completed 3 |
| Phase 4 | 6 | Completed 4, Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Exubera: new trials by email Literature Review of Exubera trials Research Report on Exubera
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Follow-Up Study for Exubera Exubera, Randomized diabetes therapy - Diabetes Mellitus | Completed | Pfizer | 7439 | 2008-08-01 | 2012-10-23 | |
| Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents Inhaled insulin (Exubera), Subcutaneous Insulin (subject's prescribed) - Diabetes Mellitus, Type 1 | Phase 3 | Terminated | Pfizer | 2 | 2007-10-01 | 2018-10-01 |
| Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes CP-464,005 - Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1 | Phase 3 | Terminated | Pfizer | 24 | 2007-08-01 | 2009-10-15 |
| A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera. Inhaled Human Insulin (Exubera) - Diabetes Mellitus, Type 2 | Phase 4 | Terminated | Pfizer | 49 | 2007-06-01 | 2009-05-11 |
| This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus Insulin glargine, Inhaled Insulin (Exubera) - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Pfizer | 413 | 2007-03-01 | 2026-08-11 |
| A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus® Insulin Glargine (Lantus®), Inhaled Human Insulin (Exubera®) - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Pfizer | 261 | 2006-12-01 | 2026-08-11 |
| A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog® Inhaled Human Insulin (Exubera®), Insulin lispro (Humalog) - Diabetes Mellitus, Type 1 | Phase 4 | Terminated | Pfizer | 58 | 2006-11-01 | 2009-09-02 |
| A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus Inhaled Human Insulin (Exubera), Insulin Glargine (Lantus) - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Pfizer | 30 | 2006-09-01 | 2008-01-29 |
| Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes Insulin Lispro, Exubera - Diabetes Mellitus | Phase 3 | Completed | Pfizer | 191 | 2006-06-01 | 2010-03-16 |
| Study to Estimate the Effects of Inhaled Versus Intravenous (IV) Infusion of Human Insulin in Subjects With Type 1 Diabetes Exubera - Type 1 Diabetes Mellitus | Phase 4 | Completed | University of Pittsburgh | 12 | 2006-04-01 | 2008-02-18 |
| A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus Inhaled Insulin (Exubera), Standard of Care - Diabetes Mellitus Type 2 | Phase 3 | Terminated | Pfizer | 354 | 2006-03-06 | 2019-04-02 |
| US Inhaled Insulin Dose Titration Study Exubera (inhaled insulin), 8-point glucose diary (to assess pre- and post prandial glucoses), Meal Tolerance Test - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Pfizer | 120 | 2005-11-01 | 2008-02-08 |
| Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus Exubera® (inhaled insulin) - Diabetes Mellitus | Phase 2 | Terminated | Pfizer | 173 | 2003-03-01 | 2010-04-15 |
| Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes Inhaled Insulin, Subcutaneous insulin - Diabetes Mellitus | Phase 3 | Terminated | Pfizer | 635 | 2002-06-01 | 2010-02-18 |
| Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes Inhaled human insulin (EXUBERA™) - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Pfizer | 300 | 1999-09-01 | 2007-02-13 |
Diabetes Mellitus, Type 2 (8) · Diabetes Mellitus (5) · Diabetes Mellitus, Type 1 (4) · Insulin Resistance (2)
Pfizer (14) · University of Pittsburgh (1)
United States (11) · Canada (4) · France (4) · Spain (4) · Sweden (4) · Belgium (3) · Finland (3) · Netherlands (3) · Norway (3) · Portugal (3) · Puerto Rico (3) · Austria (2) · Brazil (2) · Denmark (2) · Germany (2)
PMID 18535196, PMID 19905885, PMID 31331907
2005 (1)